All News

By the time you read this, Pfizer Inc. will be close to beginning distribution of its COVID-19 vaccine.

What a year 2020 has been! We hope to look back on it and recognize it as an outlier or anomaly—hoping life will at some point return to normal.

As the year comes to a close, we would like to recognize all of the people who have contributed to the growth and continued success of Contemporary OB/GYN.

In the largest meta-analysis study to date, researchers find that a levonorgestrel-intrauterine system (LNG-IUS) used for 3 to 6 months is likely more effective than non‐intrauterine progestogens for reversing endometrial hyperplasia (EH).

What to look for this week on Contemporary OB/GYN

Agile Therapeutics, Inc. announced today the U.S. commercial launch of Twirla (levonorgestrel and ethinyl estradiol) transdermal system, a new non-daily, non-invasive contraceptive patch.

Seven women’s health-focused organizations have formed the Alliance for Endometriosis to improve the lives of women afflicted with the disease.

A Chinese study found that low‐dose computed tomography (LDCT) imaging is a viable alternative to standard dual‐energy X‐ray absorptiometry (DXA) scans for the opportunistic screening of osteoporosis.

It was a very busy week for the Contemporary OB/GYN team.

The vast majority of cancer survivors reported that they experience sexual side effects after chemotherapy, radiation and other cancer treatments according to the results of a survey presented at the annual meeting of the American Society for Radiation Oncology.

It has yet to be fully elucidated why postmenopausal women have a higher prevalence of benign paroxysmal positional vertigo (BPPV); however, the sudden decrease in estrogen during menopause can cause a rapid decrease in estrogen receptors, which may disturb otoconial metabolism and thus, increase the prevalence of BPPV.

Postmenopausal women with elevated hypertension who participated in the high-intensity team sport of floorball, a form of indoor hockey, achieved a significant decrease in their blood pressure.

The study in the Brazilian Journal of Nursing also found that the IUD complications were the same as those commonly cited in the literature.

The ever-use of an intrauterine device (IUD) reduces the risk of ovarian cancer by an average of 30%, according to a rigorous meta-analysis in the Journal of Obstetrics and Gynaecology.

This episode of Pap Talk by Contemporary OB/GYN features David Abel, MD, as he discusses various elements of skeletal dysplasia and how practitioners can help their patients.

We want to hear from you.

Moderna announced yesterday its plan to apply for emergency FDA authorization for its COVID-19 vaccine candidate.

The findings provide novel information on the outcome in pregnancy that are counter to smaller reports.

Data on COVID-19 during pregnancy, as reported by the CDC, in collaboration with state, local, and territorial health departments and external partners.

What to look for this week on Contemporary OB/GYN

It was a very busy week for the Contemporary OB/GYN team.

Officials with Operation Warp Speed said that COVID-19 vaccine distribution will begin 24 hours after the Food and Drug Administration's (FDA) approval.

Less than half of ob/gyns offer their patients the two most effective forms of emergency contraception -- ulipristal acetate and the copper intrauterine device (IUD) -- according to a national survey.

The risk of opioid use after endometriosis diagnosis is significantly greater in patients who used opioids before diagnosis, according to a retrospective analysis of data from a large health database.

The results of this retrospective study reflect experience with both vaginal and cesarean deliveries early in the pandemic, in comparison with similar periods in 2018 and 2019.

Heavily pretreated ovarian cancer patients who received a combination therapy of a novel engineered interleukin-2 (IL-2) cytokine plus pembrolizumab achieved an acceptable safety profile, according to a small cohort of an ongoing phase 1/2 trial.

Pregnant women with autoimmune-related interstitial lung disease (ILD) can have safe pregnancy outcomes if closely monitored by a multidisciplinary team of physicians.

The first Enhanced Recovery After Surgery (ERAS) guideline for standardizing and optimizing perioperative care for women undergoing minimally invasive gynecologic surgery (MIGS) has been published in The Journal of Minimally Invasive Gynecology.